Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 58351-58400 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT04769492
#ChopViolence/#ChopHIV
NARecruiting
525 participants
Started: Jul 30, 2020 · Completed: Aug 30, 2024
2 conditions1 sponsor1 location
NCT04465500
EBRT and HDR Brachytherapy for Unfavorable-intermediate, High, and Very High-risk Prostate Cancer
PHASE2Recruiting
60 participants
Started: Jul 30, 2020 · Completed: Jan 1, 2029
2 conditions1 sponsor1 location
NCT06534658
Study on Multimodal Imaging and Molecular Imaging Techniques in Degenerative Dementia
N/ARecruiting
1,000 participants
Started: Jul 30, 2020 · Completed: Aug 30, 2029
2 conditions1 sponsor8 locations
NCT04565665
Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia
PHASE1/PHASE2Recruiting
70 participants
Started: Jul 29, 2020 · Completed: Apr 30, 2026
5 conditions2 sponsors1 location
NCT04636775
Microbiome in Immunotherapy naïve NSCLC Patients Receiving PD-1/L1 Blockade (MIP_NSCLC)
N/ARecruiting
46 participants
Started: Jul 29, 2020 · Completed: Dec 31, 2024
2 conditions1 sponsor3 locations
NCT05865054
Vascular MRI Evaluation in Giant Cell Arteritis (VEGA)
N/ARecruiting
400 participants
Started: Jul 29, 2020 · Completed: Jul 31, 2033
1 condition2 sponsors4 locations
NCT04490317
CARbon monoxidE intoxiCatiOn in Korea: Prospective Cohort (CARE CO Cohort)
N/ARecruiting
1,500 participants
Started: Jul 29, 2020 · Completed: Dec 31, 2035
7 conditions1 sponsor1 location
NCT04318678
CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)
PHASE1Recruiting
108 participants
Started: Jul 29, 2020 · Completed: Jul 29, 2030
4 conditions1 sponsor2 locations
NCT04071223
Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study
PHASE2Recruiting
134 participants
Started: Jul 29, 2020 · Completed: Oct 1, 2026
9 conditions1 sponsor46 locations
NCT04654338
2 Ablative RadioTherapy Treatments for Prostate Cancer
PHASE2/PHASE3Recruiting
30 participants
Started: Jul 29, 2020 · Completed: Jul 29, 2028
1 condition1 sponsor1 location
NCT04716673
Stimulation of Sleep in Patients With Epilepsy
NARecruiting
120 participants
Started: Jul 29, 2020 · Completed: Dec 31, 2025
1 condition3 sponsors1 location
NCT04169737
Acalabrutinib and Venetoclax With or Without Early Obinutuzumab for the Treatment of High Risk, Recurrent, or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
PHASE2Recruiting
168 participants
Started: Jul 29, 2020 · Completed: Jul 9, 2026
4 conditions4 sponsors1 location
NCT04429087
A Study to Test Different Doses of BI 764532 in Patients With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3
PHASE1Recruiting
300 participants
Started: Jul 29, 2020 · Completed: Feb 15, 2027
1 condition1 sponsor12 locations
NCT04429594
Study of the Incidence of SARS-CoV-2 Infection (COVID-19)
NARecruiting
1,000 participants
Started: Jul 28, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04437654
The Efficacy and Safety of Non-vItamiN K antaGonist oraL Anticoagulants for intermEdiate Stroke Risk in Patients With Atrial Fibrillation (SINGLE-AF)
PHASE4Recruiting
1,800 participants
Started: Jul 28, 2020 · Completed: Oct 31, 2028
1 condition1 sponsor1 location
NCT04526431
Tacrolimus Pharmacokinetic Subpopulations
N/ARecruiting
180 participants
Started: Jul 28, 2020 · Completed: Aug 1, 2027
2 conditions2 sponsors2 locations
NCT04332848
Susceptibility Testing Guided Versus Empirical Therapy for Refractory H. Pylori Infection
PHASE4Recruiting
360 participants
Started: Jul 28, 2020 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT04090567
Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer
PHASE2Recruiting
60 participants
Started: Jul 28, 2020 · Completed: Dec 31, 2027
15 conditions2 sponsors1 location
NCT03935750
STABILITY 2: Anterior Cruciate Ligament Reconstruction +/- Lateral Tenodesis With Patellar vs Quad Tendon
NARecruiting
1,236 participants
Started: Jul 28, 2020 · Completed: Feb 28, 2026
3 conditions4 sponsors31 locations
NCT04432220
AnticoaguLation ONE Year After Ablation of Atrial Fibrillation in Patients With Atrial Fibrillation (ALONE AF Study)
PHASE4Recruiting
840 participants
Started: Jul 28, 2020 · Completed: Oct 31, 2028
1 condition1 sponsor1 location
NCT04578392
MeSenteric SpAring Versus High Ligation Ileocolic Resection for the Prevention of REcurrent Crohn's DiseaSe (SPARES)
NARecruiting
181 participants
Started: Jul 28, 2020 · Completed: Dec 31, 2027
1 condition1 sponsor7 locations
NCT03741426
WIRE - Novel Treatments in Renal Cell Cancer
PHASE2Recruiting
60 participants
Started: Jul 27, 2020 · Completed: Nov 30, 2025
1 condition4 sponsors2 locations
NCT05551507
IN10018 in Combination With Standard Chemotherapy in High-grade Serous Epithelial Ovarian Cancer
PHASE1/PHASE2Recruiting
150 participants
Started: Jul 27, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor7 locations
NCT06636474
Evaluation of the Supported Housing System for the Inclusion of People Suffering From Mental Disorders
NARecruiting
50 participants
Started: Jul 27, 2020 · Completed: Dec 27, 2030
1 condition1 sponsor1 location
NCT05455918
Paclitaxel/Ifosfamide/Cisplatin Chemotherapy for High Risk Pediatric Germ Cell Tumor
PHASE2Recruiting
42 participants
Started: Jul 26, 2020 · Completed: Jun 30, 2028
1 condition1 sponsor1 location
NCT04713293
China Pituitary Disease Registry (CAPASITY)
N/ARecruiting
2,000 participants
Started: Jul 26, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04160000
Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure
PHASE4Recruiting
360 participants
Started: Jul 26, 2020 · Completed: Jun 30, 2025
3 conditions1 sponsor9 locations
NCT06115395
Non-invasive Ventilation Assisted Fiber-optic Bronchoscopy
NARecruiting
100 participants
Started: Jul 25, 2020 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT04512144
Mindfulness in Endometrial and Cervical Cancer
NARecruiting
120 participants
Started: Jul 25, 2020 · Completed: Jul 30, 2026
5 conditions1 sponsor1 location
NCT04282811
Observational Study Relapsed or Refractory Chronic Lymphocytic Leukemia Venetoclax-based Regimens Outside Clinical Trials in Italy
N/ARecruiting
321 participants
Started: Jul 24, 2020 · Completed: Oct 31, 2025
3 conditions1 sponsor27 locations
NCT04730453
ENB-guided Ablation Therapy Combined With VATS in the Treatment of MPLC
N/ARecruiting
30 participants
Started: Jul 24, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04706689
Development and Validation of the SWADOC Tool
N/ARecruiting
104 participants
Started: Jul 24, 2020 · Completed: Jun 30, 2025
5 conditions9 sponsors8 locations
NCT06168188
The Neuroprotective Effect of PEG-GCSF in the Traumatic Optic Neuropathy
EARLY_PHASE1Recruiting
20 participants
Started: Jul 24, 2020 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT04421768
Effects of Systematic Cervical Exam Training on Labor and Delivery Care
NARecruiting
1,125 participants
Started: Jul 23, 2020 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT04427566
Low Dose Whole Lung Radiation Therapy for Patients With COVID-19 and Respiratory Compromise
PHASE2Recruiting
24 participants
Started: Jul 23, 2020 · Completed: Dec 31, 2021
1 condition1 sponsor1 location
NCT04203082
Cognitive Behavioral Intervention to Reduce Procedural Anxiety Among Woman With High Risk Pregnancies With Scheduled Cesarean Deliveries
NARecruiting
50 participants
Started: Jul 23, 2020 · Completed: Jan 31, 2025
3 conditions1 sponsor4 locations
NCT04392960
Novel Imaging Tools in Newly-diagnosed Patients With Cardiac AL Amyloidosis
NARecruiting
69 participants
Started: Jul 22, 2020 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT04852354
Tissue Collection for Drug Screening and Bioanalysis
N/ARecruiting
500 participants
Started: Jul 22, 2020 · Completed: Jul 22, 2029
1 condition1 sponsor1 location
NCT05968417
Myeloma Novel Drug Discovery Ver 1.2
N/ARecruiting
250 participants
Started: Jul 22, 2020 · Completed: Feb 28, 2035
1 condition2 sponsors1 location
NCT04746586
Identification of Circulating microRNAs in Adolescent Idiopathic Scoliosis
N/ARecruiting
30 participants
Started: Jul 22, 2020 · Completed: Dec 21, 2025
1 condition1 sponsor1 location
NCT04356469
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
PHASE2Recruiting
17 participants
Started: Jul 22, 2020 · Completed: Jun 30, 2026
3 conditions1 sponsor1 location
NCT04414046
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
PHASE2Recruiting
17 participants
Started: Jul 22, 2020 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT06176079
Hyperpolarized Pyruvate (13C) Magnetic Resonance Imaging In Patients With Fatty Liver Disease
N/ARecruiting
80 participants
Started: Jul 22, 2020 · Completed: Feb 28, 2025
5 conditions2 sponsors1 location
NCT04489238
Collection of Information to Better Understand Young Onset Colorectal Cancer
N/ARecruiting
1,366 participants
Started: Jul 22, 2020 · Completed: Jul 22, 2026
2 conditions1 sponsor8 locations
NCT06703541
ADRC Clinical Cohort (Alzheimer's Disease)
N/ARecruiting
500 participants
Started: Jul 21, 2020 · Completed: Aug 31, 2026
3 conditions3 sponsors1 location
NCT04177914
HCRN Endoscopic Versus Shunt Treatment of Hydrocephalus in Infants
PHASE3Recruiting
176 participants
Started: Jul 21, 2020 · Completed: Aug 31, 2027
1 condition22 sponsors21 locations
NCT04198870
MitraClip REPAIR MR Study
NARecruiting
500 participants
Started: Jul 21, 2020 · Completed: Apr 30, 2034
1 condition1 sponsor85 locations
NCT04603222
Evaluation of SUMMIT BRUSH in Treatment of Blepharitis
NARecruiting
60 participants
Started: Jul 21, 2020 · Completed: Jul 18, 2022
1 condition1 sponsor3 locations
NCT04293562
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
PHASE3Recruiting
1,186 participants
Started: Jul 21, 2020 · Completed: Sep 30, 2027
1 condition2 sponsors205 locations
NCT06760832
How to Optimize Enteral Feeding of the Full Enteral Feeding Preterm Infant
N/ARecruiting
50 participants
Started: Jul 21, 2020 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location